Washington
+919359902383
+919359902383

Wholesale Sunitinib 12.5mg USA | Certified Indian Pharmaceutical Exporter | Ernest Impex

Sutekast 12.5mg Capsule: Advanced Multi-Kinase Inhibition for Targeted Cancer Therapy


Are you searching for a verified Sutekast 12.5mg Capsule exporter from IndiaErnest Impex, an integral part of the Group of Ernest Pharmaceutical Pvt. Ltd., is a leading global supplier and bulk distributor of high-tier oncology medications. We facilitate a highly reliable, temperature-monitored supply chain for Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica), ensuring that specialized targeted therapies reach hospital pharmacies with 100% pharmaceutical integrity.




Detailed Product Profile: What is Sutekast 12.5mg?


Sutekast 12.5 mg is an oral targeted therapy containing the active pharmaceutical ingredient Sunitinib. Manufactured by Kastel, this 12.5mg capsule is a potent multi-tyrosine kinase inhibitor (TKI). It is specifically designed to target the signaling pathways that malignant cells use to grow, multiply, and develop the independent blood supply required for tumor expansion.



1. Therapeutic Indications

Sutekast 12.5mg is clinically utilized globally for the treatment of:

  • Advanced Renal Cell Carcinoma (RCC): Used as a primary treatment for advanced or metastatic kidney cancer, and as adjuvant therapy for patients at high risk of recurrence following surgery.

  • Gastrointestinal Stromal Tumors (GIST): Indicated for patients whose disease has progressed or who have shown intolerance to Imatinib.

  • Pancreatic Neuroendocrine Tumors (pNET): For the treatment of progressive, well-differentiated pNET in patients with unresectable or metastatic disease.



2. Mechanism of Action: The Multi-Targeted Attack


Sutekast works by simultaneously blocking several receptors on the surface of cancer cells and surrounding blood vessels:

  • VEGFR Inhibition: By blocking Vascular Endothelial Growth Factor Receptors, it prevents the formation of new blood vessels (angiogenesis), effectively "starving" the tumor.

  • PDGFR Blockade: Inhibits Platelet-Derived Growth Factor Receptors, which are critical for tumor cell survival and recruitment of supporting tissues.

  • KIT & FLT3 Targeting: Directly interferes with the internal growth signals of the cancer cell, halting uncontrolled cell division.


3. Administration and Cycle Management

  • Cycle Protocols: For RCC and GIST, the standard regimen is often a "4 weeks on, 2 weeks off" schedule (Schedule 4/2). For pNET, it is typically taken as a continuous daily dose.

  • Flexibility: The 12.5mg strength is crucial for precise dose titration, allowing oncologists to adjust the daily intake (e.g., 25mg, 37.5mg, or 50mg) based on patient tolerance and clinical response.

  • Usage: It can be taken with or without food. Capsules must be swallowed whole.




Clinical Side Effects & Safety Monitoring

Patients on Sutekast 12.5mg require regular medical supervision to manage potential side effects:

  • Hematological Health: Potential for Neutropenia (low white blood cells) and Thrombocytopenia (low platelets). Frequent Complete Blood Counts (CBC) are mandatory.

  • Cardiovascular Safety: Monitoring for Hypertension (high blood pressure) and heart function (LVEF) is required, as the drug can impact cardiac performance.

  • Hepatotoxicity: Liver function must be monitored closely for enzyme elevations or rare liver failure.

  • Dermatological Reactions: Potential for Hand-Foot Syndrome (redness, pain, or blisters on palms and soles) and changes in skin or hair pigmentation.

  • Thyroid Function: Regular checks for hypothyroidism are recommended throughout the treatment period.



Why Source Sutekast 12.5 mg from Ernest Impex?


In 2026, global pharmaceutical procurement relies on Supply Chain Resilience and Direct Traceability. Ernest Impex offers:

  • Verified Authenticity: Direct sourcing of Kastel’s Sutekast with full batch-specific traceability and COA.

  • Logistics Authority: Expert handling of complex international import/export regulations for Washington, London, Bangkok, Canberra, Singapore, and Kingston.

  • Wholesale Fulfillment: Competitive bulk pricing and steady inventory for institutional buyers and regional distributors.

  • Regulatory Compliance: Every shipment is accompanied by GMP certificates and complete B2B documentation.


πŸ“ž Contact Ernest Impex β€” Pharmaceutical Exporter from India


[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]

🌐 Websites:

πŸ“§ Email: exports@ernestpharmaceuticals.com

πŸ“¦ Business Type: Exporter | Bulk Supplier | Distributor 

πŸ“² WhatsApp: +91 93599 02383 

πŸ”— Direct Link: Chat on WhatsApp

 2026-04-28T10:50:30

Keywords